Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
41 studies found for:    " January 19, 2011":" February 18, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" January 19, 2011":" February 18, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Reactogenicity and Immunogenicity of Cervico-vaginal CN54gp140-hsp70 Conjugate Vaccine
Condition: HIV Infections
Intervention: Biological: CN54gp140 glycoprotein-hsp70 conjugate vaccine
2 Unknown  Structured Treatment Interruption (STI) in Acute/Primary HIV
Condition: HIV Infections
Intervention: Other: Gradual anti-HIV treatment interruption
3 Unknown  Assessment of Normal Value of Acoustic Radiation Force Impulse (ARFI) Elastography in HIV Patients
Condition: HIV Infection
Intervention: Device: Acoustic radiation force impulse imaging
4 Completed Comparing Continuing Tenofovir, Emtricitabine (or Lamivudine) Plus Lopinavir and Switching to Raltegravir Plus Darunavir
Condition: HIV Infections
Intervention: Drug: Raltegravir, Darunavir/r
5 Active, not recruiting Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy
Condition: HIV Infection
Intervention: Drug: Pegylated Interferon Alpha 2b (PEGINTRON)
6 Unknown  The Pharmacology/Aging Clinic
Condition: HIV Infection
Intervention:
7 Recruiting Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents
Condition: HIV Infections
Interventions: Drug: Dolutegravir (DTG) film-coated tablets;   Drug: DTG granules for suspension;   Drug: DTG dispersible tablets
8 Unknown  Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult Subjects
Condition: HIV Infection
Intervention: Biological: Hepavax-Gene
9 Completed Progression of HIV-Disease Under Low Dose Corticosteroids
Condition: HIV Disease Progression
Intervention: Drug: Prednisolone
10 Completed Observational Study on Predictors of Response to Invirase (Saquinavir) Treatment in Treatment-naïve Patients With HIV Infection
Condition: HIV Infections
Intervention:
11 Terminated Raltegravir Cerebrospinal Fluid Pharmacodynamic Study in HIV-Infected Individuals
Condition: HIV
Interventions: Drug: Raltegravir;   Drug: Efavirenz
12 Completed Comparing the PrePex™ Device to Surgical Circumcision for Rapid Scale Up of Male Circumcision in Resource Limited Setting
Condition: HIV
Interventions: Device: PrePex™ device for adult male circumcision;   Procedure: Surgical circumcision
13 Active, not recruiting Pilot Study of Maraviroc/Raltegravir for Naive HIV-1 Patients
Condition: HIV
Intervention: Drug: MVC/RAL/FTC/TDF followed by Maraviroc/Raltegravir
14 Terminated Lenalidomide in Kaposi Disease Associated With HIV Infection
Condition: HIV Infection Associated Kaposi Disease
Intervention: Drug: Lenalidomide
15 Completed
Has Results
Interferon Alfa Sensitivity in HIV/HCV Persons Before and After HIV Meds
Conditions: HIV Infection;   Hepatitis C
Interventions: Drug: Antiretroviral therapy (ART);   Drug: raltegravir;   Drug: Emtricitabine and tenofovir disoproxil fumarate
16 Completed Pharmacokinetic Study of the HCV Protease Inhibitor Boceprevir and the HIV Integrase Inhibitor Raltegravir
Conditions: HIV Infections;   HCV Infections
Interventions: Drug: boceprevir;   Drug: raltegravir
17 Completed Internet-Based Sexual Health Education for Middle School Native American Youth
Conditions: Sexually Transmitted Diseases;   Pregnancy;   HIV Infections
Interventions: Behavioral: HIV, STI and Pregnancy Prevention Curriculum;   Behavioral: Control Curricula
18 Completed Safety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers
Condition: Prevention of Infection With HIV-1
Intervention: Biological: ibalizumab (biologic/MAb) for SC Injection or placebo
19 Completed An Automated, Tailored Information Application for Medication Health Literacy
Condition: Human Immunodeficiency Virus I Infection
Intervention: Behavioral: Tailored Information
20 Active, not recruiting The Yellow Fever Vaccine Immunity in HIV Infected Patients : Development of New Assays for Virological and Immunological Monitoring in HIV Infected Patient.
Conditions: HIV Infection;   Yellow Fever
Intervention: Biological: Yellow fever vaccination (STAMARIL)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.